Cargando…

Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.

BACKGROUND: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. METHODS: We conducted a multicenter p...

Descripción completa

Detalles Bibliográficos
Autores principales: MAHJOUB, Lobna, YOUSSEF, Rym, YAAKOUBI, Hajer, SALAH, Houda BEN, JABALLAH, Rahma, MEJRI, Moez, SEKMA, Adel, TRABELSI, Imen, NOUIRA, Semir, KHROUF, Mariem, SOLTANE, Houda BEN, MEZGAR, Zied, BOUKADIDA, Lotfi, ZORGATI, Asma, BOUKEF, Riadh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281695/
https://www.ncbi.nlm.nih.gov/pubmed/37419768
http://dx.doi.org/10.1016/j.explore.2023.06.009
_version_ 1785061047655202816
author MAHJOUB, Lobna
YOUSSEF, Rym
YAAKOUBI, Hajer
SALAH, Houda BEN
JABALLAH, Rahma
MEJRI, Moez
SEKMA, Adel
TRABELSI, Imen
NOUIRA, Semir
KHROUF, Mariem
SOLTANE, Houda BEN
MEZGAR, Zied
BOUKADIDA, Lotfi
ZORGATI, Asma
BOUKEF, Riadh
author_facet MAHJOUB, Lobna
YOUSSEF, Rym
YAAKOUBI, Hajer
SALAH, Houda BEN
JABALLAH, Rahma
MEJRI, Moez
SEKMA, Adel
TRABELSI, Imen
NOUIRA, Semir
KHROUF, Mariem
SOLTANE, Houda BEN
MEZGAR, Zied
BOUKADIDA, Lotfi
ZORGATI, Asma
BOUKEF, Riadh
author_sort MAHJOUB, Lobna
collection PubMed
description BACKGROUND: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. METHODS: We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms’ according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support. RESULTS: One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the (5th) day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial. CONCLUSIONS: Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness.
format Online
Article
Text
id pubmed-10281695
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-102816952023-06-21 Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. MAHJOUB, Lobna YOUSSEF, Rym YAAKOUBI, Hajer SALAH, Houda BEN JABALLAH, Rahma MEJRI, Moez SEKMA, Adel TRABELSI, Imen NOUIRA, Semir KHROUF, Mariem SOLTANE, Houda BEN MEZGAR, Zied BOUKADIDA, Lotfi ZORGATI, Asma BOUKEF, Riadh Explore (NY) Article BACKGROUND: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. METHODS: We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms’ according to the time from randomization to clinical improvement. The pre-specified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support. RESULTS: One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the (5th) day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial. CONCLUSIONS: Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness. Elsevier Inc. 2023-06-20 /pmc/articles/PMC10281695/ /pubmed/37419768 http://dx.doi.org/10.1016/j.explore.2023.06.009 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
MAHJOUB, Lobna
YOUSSEF, Rym
YAAKOUBI, Hajer
SALAH, Houda BEN
JABALLAH, Rahma
MEJRI, Moez
SEKMA, Adel
TRABELSI, Imen
NOUIRA, Semir
KHROUF, Mariem
SOLTANE, Houda BEN
MEZGAR, Zied
BOUKADIDA, Lotfi
ZORGATI, Asma
BOUKEF, Riadh
Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
title Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
title_full Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
title_fullStr Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
title_full_unstemmed Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
title_short Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study.
title_sort melatonin, vitamins and minerals supplements for the treatment of covid-19 and covid-like illness: a prospective, randomized, double-blind multicenter study.
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281695/
https://www.ncbi.nlm.nih.gov/pubmed/37419768
http://dx.doi.org/10.1016/j.explore.2023.06.009
work_keys_str_mv AT mahjoublobna melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT youssefrym melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT yaakoubihajer melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT salahhoudaben melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT jaballahrahma melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT mejrimoez melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT sekmaadel melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT trabelsiimen melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT nouirasemir melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT khroufmariem melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT soltanehoudaben melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT mezgarzied melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT boukadidalotfi melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT zorgatiasma melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy
AT boukefriadh melatoninvitaminsandmineralssupplementsforthetreatmentofcovid19andcovidlikeillnessaprospectiverandomizeddoubleblindmulticenterstudy